Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Surgical Equipment Companies

Several companies were prominent in the manufacturing and development of surgical equipment. Surgical equipment encompasses a wide range of devices and instruments used in various medical procedures, including cutting, dissecting, suturing, and more. Keep in mind that the landscape may have changed, and new companies may have emerged since my last update.

Surgical Equipment Key Companies

Latest Surgical Equipment Companies Update

Oct 2023: On October 26, the India division of Novartis AG, a global pharmaceutical corporation headquartered in Switzerland, declared a scarcity of the immunosuppressive medication "Simulect 20 mg" in India. The pharmaceutical company stated in an exchange filing: "This is to notify that 'Simulect 20 mg,' one of Novartis India Limited's medicines, is now experiencing a shortage. It said, "But the company is making every effort to mitigate the supply issue sustainably." Patients undergoing kidney transplants frequently utilize the intravenous prescription medication Simulect (basiliximab injection). The Novartis medication costs between Rs 67,500 and Rs 68,000 per vial. Transplant patients utilize it to make sure their bodies do not reject

Jan 2023: A definitive agreement was revealed by CONMED Corporation to buy privately held Biorez, Inc. (Biorez) for a cash consideration of $85 million at closing, pending modification, and up to an additional $165 million in growth-based earnout transactions over four years. The acquisition will be completed on a debt-free and cash-free basis. The company's current credit facility is anticipated to be used to finance the acquisition. Based in New Haven, Connecticut, Biorez is a start-up company focused on medical devices that use its patented BioBrace® Implant technology to improve soft tissue healing. The BioBrace implant is a novel bioinductive scaffold designed to promote healing by reinforcing soft tissue in areas of weakness. The FDA has approved BioBrace® for usage in a variety of product sizes.List of Surgical Equipment Key companies in the market

Medtronic Plc.

Peters Surgical SASU

Johnsons & Johnsons

Conmed Corporation

Novartis International AG

Smith & Nephew PLC

Boston Scientific Corporation

B. Braun Melsungen AG

Cousin-Biotech

Enthral Medical GMBH

Fuhrmann GMBH

Integral Lifesciences Holdings Corporation

KLS Martin Group

Surgical Equipment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.